Draganfly successfully completed initial drone delivery flights for Mass General Brigham's Home Hospital project, aiming to enhance healthcare logistics.
Quiver AI Summary
Draganfly Inc. has completed initial test flights in a proof-of-concept project for Mass General Brigham's Home Hospital care, showcasing its medical drone delivery infrastructure aimed at improving healthcare logistics. This collaboration involves mapping potential delivery routes and conducting test flights within hospital premises, although these flights did not yet contribute directly to patient care. The project is focused on the greater Boston area and intends to demonstrate how drones can enhance access to essential medical supplies while reducing delays from traffic and traditional delivery methods. Draganfly's CEO highlighted the initiative as a key step towards more efficient healthcare delivery, emphasizing the potential benefits for patients and healthcare providers. The company also participated in the World Medical Innovation Forum, showcasing their technologies aimed at transforming healthcare logistics.
Potential Positives
- Successful initial flights in collaboration with Mass General Brigham signify progress in Draganfly's drone delivery project for healthcare logistics.
- The project aims to innovate and improve timely access to critical medical supplies, potentially transforming Home Hospital care.
- Participation in the World Medical Innovation Forum showcases Draganfly's commitment to advancing medical technology and establishing industry leadership.
Potential Negatives
- This initiative involved only preliminary proof-of-concept flights that did not contribute to actual care delivery, indicating limited immediate impact on healthcare logistics.
- The reliance on forward-looking statements highlights uncertainties regarding the technology's ability to effectively address healthcare logistics challenges, which may diminish investor confidence.
- The acknowledgment of various risks, including potential impacts from public health crises and regulatory restrictions, suggests vulnerabilities that could affect the company's operations and market perception.
FAQ
What is Draganfly's recent project with Mass General Brigham?
Draganfly's project involves a proof-of-concept for drone delivery of medical supplies to optimize Home Hospital care.
How will drone deliveries impact healthcare logistics?
The drones aim to minimize delays caused by traffic congestion and enhance timely access to critical medical supplies.
Where is the initial phase of drone deliveries taking place?
The initial phase focuses on the greater Boston metropolitan area to evaluate healthcare delivery logistics.
What innovations did Draganfly display at the World Medical Innovation Forum?
Draganfly showcased technologies related to its medical delivery project, highlighting advancements in healthcare logistics and support.
How long has Draganfly been in the drone industry?
Draganfly has over 24 years of experience in creating cutting-edge drone solutions and systems across various markets.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$DPRO Hedge Fund Activity
We have seen 2 institutional investors add shares of $DPRO stock to their portfolio, and 34 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ARMISTICE CAPITAL, LLC removed 6,473,000 shares (-100.0%) from their portfolio in Q3 2024
- RENAISSANCE TECHNOLOGIES LLC removed 402,910 shares (-100.0%) from their portfolio in Q2 2024
- CITADEL ADVISORS LLC removed 165,125 shares (-100.0%) from their portfolio in Q2 2024
- WARBERG ASSET MANAGEMENT LLC removed 139,568 shares (-100.0%) from their portfolio in Q2 2024
- ALLIANCE WEALTH ADVISORS, LLC removed 103,000 shares (-100.0%) from their portfolio in Q3 2024
- TORNO CAPITAL, LLC removed 100,000 shares (-100.0%) from their portfolio in Q2 2024
- THOROUGHBRED FINANCIAL SERVICES, LLC removed 60,000 shares (-100.0%) from their portfolio in Q3 2024
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
Draganfly’s medical drone delivery infrastructure offers new model for future improvement in service time for Home Hospital care
Boston, MA., Dec. 18, 2024 (GLOBE NEWSWIRE) --
Draganfly Inc.
(NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8A) ("Draganfly" or the "Company"), an award-winning, industry-leading drone solutions and systems developer, today announced the successful completion of initial flights as part of a proof-of-concept, research-and-development drone delivery project for
Mass General Brigham (MGB) Home Hospital
.
This initial phase involved collaborating with MGB and regulators to evaluate and map potential routes as well as complete test flights that included takeoff and landing within hospital infrastructure. These test flights did not contribute to care delivery. This initiative aims to demonstrate how drone deliveries could ensure timely access to critical medical supplies or laboratory samples, thereby minimizing traditional logistical delays.
Phase One of the project focuses on the greater Boston metropolitan area to identify how Draganfly’s proprietary drone technology addresses healthcare logistics challenges by reducing delays caused by traffic congestion and outdated delivery methods.
"This is a first step toward our vision of someday delivering high-quality healthcare directly to patients' homes in a more timely and cost-effective manner,” said Dr. David Levine, MD, MPH, MA, Clinical Director of Research & Development at Mass General Brigham Healthcare at Home.
"We are thrilled to see the progress of our drone delivery services with Mass General Brigham. Draganfly’s hope is to establish a transformation in how healthcare providers manage logistics, enabling faster, more reliable delivery of essential supplies that directly benefits patients and care providers alike," commented Cameron Chell, CEO of Draganfly.
Draganfly also participated in the
World Medical Innovation Forum
, an annual event run by Mass General Brigham that focuses on the latest advancements in medical technology and healthcare innovations. The Forum, which ran from September 23-25 in Boston, MA, attracted healthcare professionals and leaders in medical research and development to discuss and explore new ways to improve patient care and treatment options. Draganfly displayed various technologies used in the medical delivery project during the event.
About Draganfly
Draganfly Inc. is the creator of quality, cutting-edge drone solutions, software, and AI systems that revolutionize how organizations operate and serve their stakeholders. With over 24 years of innovation, Draganfly is recognized as a leader in the public safety, agriculture, industrial inspections, security, mapping, and surveying markets. The Company’s commitment to ingenuity and first-class services drives its goal to save time, money, and lives across the globe.
For more information on Draganfly, please visit
Draganfly’s website
. For additional investor information, visit:
Media Contact
Erika Racicot Email:
media@draganfly.com
Company Contact
Email:
info@draganfly.com
Forward-Looking Statements
This release contains certain “forward looking statements” and certain “forward-looking information” as defined under applicable securities laws. Forward-looking statements and information can generally be identified by the use of forward-looking terminology such as “may”, “will”, “expect”, “intend”, “estimate”, “anticipate”, “believe”, “continue”, “plans” or similar terminology. Forward-looking statements and information are based on forecasts of future results, estimates of amounts not yet determinable and assumptions that, while believed by management to be reasonable, are inherently subject to significant business, economic and competitive uncertainties and contingencies. Forward-looking statements include, but are not limited to, statements with respect to the ability of drones to address healthcare logistics challenges by reducing delays caused by traffic congestion and outdated delivery methods. Forward-looking statements and information are subject to various known and unknown risks and uncertainties, many of which are beyond the ability of the Company to control or predict, that may cause the Company’s actual results, performance or achievements to be materially different from those expressed or implied thereby, and are developed based on assumptions about such risks, uncertainties and other factors set out here in, including but not limited to: the potential impact of epidemics, pandemics or other public health crises, including the COVID-19 pandemic, on the Company’s business, operations and financial condition; the successful integration of technology; the inherent risks involved in the general securities markets; uncertainties relating to the availability and costs of financing needed in the future; the inherent uncertainty of cost estimates; the potential for unexpected costs and expenses, currency fluctuations; regulatory restrictions; and liability, competition, loss of key employees and other related risks and uncertainties disclosed under the heading “Risk Factors“ in the Company’s most recent filings filed with securities regulators in Canada on the SEDAR website at
www.sedar.com
and with the United States Securities and Exchange Commission (the “SEC”) on EDGAR through the SEC’s website at
www.sec.gov
.
The Company undertakes no obligation to update forward-looking information except as required by applicable law. Such forward-looking information represents managements’ best judgment based on information currently available. No forward-looking statement can be guaranteed and actual future results may vary materially. Accordingly, readers are advised not to place undue reliance on forward-looking statements or information.
This article was originally published on Quiver News, read the full story.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
